These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27594132)

  • 1. Inappropriate implantable cardioverter-defibrillator shock in unusual circumstances.
    Suran MC; Margulescu AD; Siliste C; Vinereanu D
    Acta Cardiol; 2016 Jun; 71(3):369-70. PubMed ID: 27594132
    [No Abstract]   [Full Text] [Related]  

  • 2. Apparent inappropriate shocks from an implantable cardioverter defibrillator:
    Moore DR; Kok LC; Vijayaraman P
    J Cardiovasc Electrophysiol; 2004 Jan; 15(1):116-7. PubMed ID: 15028086
    [No Abstract]   [Full Text] [Related]  

  • 3. Shocking truths about implantable cardioverter defibrillator monitoring zones.
    Mansour F; Thibault B; Dubuc M; Guerra PG; Macle L; Brugada R; Roy D; Talajic M; Khairy P
    Pacing Clin Electrophysiol; 2007 Sep; 30(9):1146-8. PubMed ID: 17725760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implantable cardioverter-defibrillator discharges despite successful termination of ventricular tachycardia by antitachycardia pacing.
    Ho RT
    Pacing Clin Electrophysiol; 2009 Jun; 32(6):791-3. PubMed ID: 19545344
    [No Abstract]   [Full Text] [Related]  

  • 5. Ventricular oversensing after replacement of an implantable cardioverter-defibrillator.
    Arias MA; Puchol A; Castellanos E; Pachón M; Rodríguez-Padial L
    Pacing Clin Electrophysiol; 2009 Jul; 32(7):925-7. PubMed ID: 19572871
    [No Abstract]   [Full Text] [Related]  

  • 6. Failure of an implantable cardioverter-defibrillator to detect sustained ventricular tachycardia: a consequence of the latching phenomenon.
    Altman EJ; Gross JN; Fisher JD; Krumerman A
    Heart Rhythm; 2007 Jun; 4(6):785-7. PubMed ID: 17556204
    [No Abstract]   [Full Text] [Related]  

  • 7. Inappropriate Shock Due to Myopotential Oversensing in a Patient With Subcutaneous Implantable Cardioverter-Defibrillator.
    Alasti M; Machado C; Kotschet E; Alison J
    Heart Lung Circ; 2019 Apr; 28(4):e88-e90. PubMed ID: 30482685
    [No Abstract]   [Full Text] [Related]  

  • 8. Death due to an implantable cardioverter defibrillator.
    Messali A; Thomas O; Chauvin M; Coumel P; Leenhardt A
    J Cardiovasc Electrophysiol; 2004 Aug; 15(8):953-6. PubMed ID: 15333095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of flecainide therapy on inappropriate shocks and arrhythmias in catecholaminergic polymorphic ventricular tachycardia.
    Jacquemart C; Ould Abderrahmane F; Massin MM
    J Electrocardiol; 2012; 45(6):736-8. PubMed ID: 22672791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initiation of ventricular tachycardia by interruption of pacemaker-mediated tachycardia in a patient with a dual-chamber implantable cardioverter defibrillator.
    Van Gelder BM; Meijer A; Dekker LR; Bracke FA
    Pacing Clin Electrophysiol; 2009 Sep; 32(9):1227-30. PubMed ID: 19719503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Troubleshooting of small R-wave with inappropriate implantable cardioverter-defibrillator shock.
    Baldinger SH; Kadner A; Delacrétaz E
    Europace; 2014 Jun; 16(6):854. PubMed ID: 24008497
    [No Abstract]   [Full Text] [Related]  

  • 12. Inappropriate implantable cardioverter-defibrillator shock due to external alternating current leak: report of two cases.
    Chan NY; Wai-Ling Ho L
    Europace; 2005 Mar; 7(2):193-6. PubMed ID: 15763537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repetitive Periodic Atrial Oversensing in a Cardiac Implantable Electrical Defibrillator at 35 Minutes and 50 Minutes Past the Hour: What Is the Diagnosis?
    Hu YL; Kaszala K; Huizar J; Ellenbogen KA; Tan AY
    Pacing Clin Electrophysiol; 2016 Sep; 39(9):1018-21. PubMed ID: 27356808
    [No Abstract]   [Full Text] [Related]  

  • 14. Inappropriate implantable cardioverter defibrillator shock from a transcutaneous muscle stimulation device therapy.
    Siu CW; Tse HF; Lau CP
    J Interv Card Electrophysiol; 2005 Jun; 13(1):73-5. PubMed ID: 15976983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inappropriate defibrillator discharges caused by an unusual interaction between an implantable cardioverter defibrillator and a pacemaker.
    Liao PC; Lai LP; Lin JL; Huang SK
    J Cardiovasc Electrophysiol; 2002 Nov; 13(11):1178-9. PubMed ID: 12475114
    [No Abstract]   [Full Text] [Related]  

  • 16. Recurrence of ventricular tachycardia degeneration by low-energy implantable cardioverter-defibrillator shocks: a case report.
    Cagli KE; Guray U; Akpinar I; Sen N; Aras D; Topaloglu S
    J Electrocardiol; 2010; 43(1):68-70. PubMed ID: 19446839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ICD proarrhythmia as a consequence of an interaction with an algorithm to prevent atrial arrhythmias.
    Martínez-Sánchez J; García-Alberola A; Sánchez-Muñoz JJ; Peñafiel-Verdú P; Giner-Caro JA; Valdés-Chávarri M
    Pacing Clin Electrophysiol; 2009 Aug; 32(8):1096-8. PubMed ID: 19659632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of ventricular tachycardia by alternate current due to an insufficiently grounded electrical system.
    Lappegård KT
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):e170-2. PubMed ID: 21091734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twiddler syndrome with 180degrees rotation of an implantable cardioverter defibrillator generator resulting in malfunction of one of the shocking coils.
    Chemello D; Subramanian A; Cameron D
    Europace; 2009 Oct; 11(10):1259. PubMed ID: 19797142
    [No Abstract]   [Full Text] [Related]  

  • 20. Inappropriate implantable cardioverter-defibrillator therapy during exercise: what is the mechanism?
    Vollmann D; Lüthje L; Zabel M
    Heart Rhythm; 2009 May; 6(5):718-9. PubMed ID: 19303370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.